Arrow Generiques, the French unit of Aurobindo Pharma, has signed an agreement to purchase select commercial products in France from Teva.

Arrow Generiques will purchase the right, title and interest in products Calcium and Calcium Vitamin D3, including the  use of the OROCAL trademark.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The deal is subject to approval of the European Commission.  

After the receipt of approvals from European authorities, Arrow Generiques will merge these products with its existing commercial operations in France, and focus on maximising their potential.

Arrow Generiques and Teva plan to ensure continuity of the product supply to the market.

"This purchase will enable Arrow Generiques to continue to increase its branded products portfolio and leverage its position as a key player in the drug market."

This purchase will enable Arrow Generiques to continue to increase its branded products portfolio and leverage its position as a key player in the drug market.

Arrow Generiques focuses on selling generics for the retail and hospital markets in France since 2002.

Arrow Generiques entered a strategy of diversification with the purchase of the first branded products a few years ago to become a company balanced between generics / branded products / biosimilars within the retail and hospital markets.

A business unit with a sales and marketing team had been set up to particularly improve this business.

This deal will bolster its presence of Arrow Generiques and open new opportunities for the future.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients.